Chloroquine treatment affects T-cell priming to minor histocompatibility antigens and graft-versus-host disease.


Graft-versus-host disease (GVHD) caused by T-cell recognition of minor histocompatibility (MiHC) antigens is a major complication of bone marrow transplantation. GVHD therapy has focused on removal or suppression of donor T cells, but modulation of MiHC antigen presentation to CD4+ T cells may represent an alternative approach. Chloroquine is known to… (More)


6 Figures and Tables

Slides referencing similar topics